The problem with comparing to beyond and other companies is that VRUS isn't on the NASDAQ, its on the OTC. No OTC stock is going to get as much support and credibility as new hyped stocks that IPO'd to the NASDAQ. Those stocks also had multiple rounds of private equity financing before going public.
Market Data 
Markets 
AI
